Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-03-21
2006-03-21
Goldberg, Jeanine A. (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091200, C536S023100, C536S024300, C536S024330
Reexamination Certificate
active
07014999
ABSTRACT:
The present invention pertains to a method for topographic genotyping. The method comprises the steps of placing a biological specimen having DNA of a patient under a microscope. Then there is the step of inspecting the biological specimen microscopically with the microscope. Next there is the step of choosing a microscope size target on the biological specimen based on its histopathologic characteristics. Next there is the step of separating the target from the specimen. Then there is the step of obtaining DNA sequences from the target so the DNA sequences can be amplified. Next there is the step of amplifying the DNA sequences. Then there is the step of detecting mutations in the DNA sequences. The present invention pertains to a method for topographic genotyping. The method comprises the steps of separating a section from a specimen of fixative treated tissue. Then there is the step of obtaining DNA sequences from the section. Next there is the step of amplifying the DNA sequences by cyphaling them in a PCR machine, with each cycle heating them to a temperature no greater than 99° C., and then back to a temperature of 55° C. in 5 minutes. Next there is the step of detecting mutations in the DNA sequences. Preferably, the separating step includes the step of cutting one to three 2–6 micron thick histeologic sections from the specimen.
REFERENCES:
patent: 5320840 (1994-06-01), Camble et al.
patent: 5380645 (1995-01-01), Vogelstein
patent: 5491062 (1996-02-01), McKenzie et al.
patent: 5580728 (1996-12-01), Perlin
patent: 5843644 (1998-12-01), Liotta et al.
patent: 6340563 (2002-01-01), Finkelstein et al.
Innis et al. PCR Protocols. Adademic Press, Inc. pp. 3-12, 153-158, 348-355, 1990.
Teramoto et al. “Application of PCR to the microscopically identified cells on the slides” Acta Med. Okayama, vol. 48, No. 4, pp. 189-193, 1994.
Shibata et al. “Specific Genetic Analysis of microscopic tissue after selective ultraviolet radiation fraction and the PCR”, Am. J. of Pathology, vol. 121, No. 3, pp. 539-543, Sep. 1992.
Kuppers et al. “tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections”, EMBO J. vol. 12, No. 13, pp. 4955-4967, 1993.
Meltzer et al. Reduction to homozygosity involving p53 in esophageal cancers demonstrated by PCR. PNAS, vol. 88, pp. 4976-4980, Jun. 1991.
Pretlow et al. “K-ras mutation in putative preneoplastic lesions in human colon”. J. of Natl. Cancer Institute, vol. 85, No. 24, pp. 2004-2007, Dec. 1993.
Erlich, Henry. PCR Technology. p. 8, 1990.
Finkelstein SD, et al., “‘Kras-2 topographic genotyping of pancreatic adenocarcinoma.’,” Arch. Surg., vol. 129 ( No. 4), p. 367-372, (Apr. 1, 1994).
Finkelstein SD, et al., “‘Genotypic classification of colorectal adenocarconoma. Biologica behavior correlates with K-ras-2 mutation type.’,” Cancer (1993), vol. 71 ( No. 12), p. 3827-3838, (Jun. 15, 1993).
Reincke M. et al., “‘p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies.’,” J. Clin Endocrin. and Metabol. (1994), vol. 78 ( No. 3), p. 790-794, (Mar. 1, 1994).
Slebos, RJC, et al., “‘K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung.’,” New Engl. J. Med. (1990), vol. 323 ( No. 9), p. 561-565, (Aug. 3, 1990).
Ben-Ezra et al.,“Effect of Fixation on the Amplification of Nucleic Acids from Paraffin-embedded Material by the polymerase Chain Reaction,”The Journal of Histochemistry and Cytochemistry, 39(3), pp. 351-354 (1991) The Histochemical Society, Inc.
Talmadge,“The pharmaceutics and delivery of therapeutic polypeptides and proteins,”Advanced Drug Delivery Reviews, 10, pp. 247-299 (1993) Elsevier Science Publishers B.V., Amsterdam, Holland.
Orkin et al., Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy (1995).
Gura“Antisense Has Growing Pains,”Science, 270, pp. 575-577, (1995) Amer. Assn. For the Advancement of Science, Washington, D.C.
Stenersen et al.,“The selection of thin epithelial layers: a method for single cell preparations of very small biopsies from the vocal cords,”Analytical Cellular Pathology, 2, pp. 253-258, (1990) Elsevier Science Publishers B.V., Amsterdam, Holland.
Oud et al.,“Extraction of Nuclei From Selected Regions in Paraffin-Embedded Tissue1,2,” Cytometry, 7, pp. 595-600 (1986) Alan R. Liss, Inc., New York.
Sen et al.,“Microdissected Double-Minute DNA Detects Variable Patterns of Chromosomal Localizations and Multiple Abundantly Expressed Transcripts In Normal and Leukemic Cells,”Genomics, 19(3), pp. 542-551 (1994) Academic Press, Inc., San Diego, CA.
Cheung Wong, et al., “Mutations in BRCA1 from Fixed, Paraffin-Embedded Tissue Can Be Artifacts of Preservation,” Cancer Genet. Cytogenet. 107, pp. 21-27 (1998).
A-M de Roda Husman et al., “Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction,” British Journal of Cancer (1995) 72, pp. 412-417.
S. Kösel et al., “Use of neuropathological tissue for molecular genetic studies: parameters affecting DNA extraction and polymerase chain reaction,” Acta Neuropathol. (1994) 88, pp. 19-25.
Zhi-Ping Ren et al., “Recovering DNA and Optimizing PCR Conditions from Microdissected Formalin-Fixed and Paraffin-Embedded Materials,” Pathobiology 2000; 68, pp. 215-217.
Carla De Giorgi et al., “Formalin-induced infidelity in PCR-amplified DNA fragments,” Molecular and Cellular Probes (1994) 8, pp. 459-462.
Takayuki Murase, M.D., et al., “Influence of Histochemical and Immunohistochemical Stains on Polymerase Chain Reaction,” The United States and Canadian Academy of Pathology, Inc., vol. 13, No. 2, pp. 147-151 (2000).
Florell M.D., “Preservation of RNA for Funcational Genomic Studies: a Multidisciplinary Tumor Bank Protocol,” The United States and Canadian Academy of Pathology, Inc., vol. 14, No. 2, pp. 116-128 (2001).
Xavier de Lamballerie, et al., “Improved current methods for amplification of DNA from routinely processed liver tissue by PCR,” Journal of Clinical Pathology 1994, 47, pp. 466-467.
S.F. An, et al., “Removal of inhibitor(s) of the polymerase chain reaction from formalin fixed, paraffin wax embedded tissues,” Journal of Clinical Pathology 1991, 44 pp. 924-927.
P.J. Coates, et al., “Simplified procedures for applying the polymerase chain reaction to routinely fixed paraffin wax sections,” Journal of Clinical Pathology 1991, 44, pp. 115-118.
Gillian Tully, et al., “Analysis of 6 VNTR loci by ‘multiplex’ PCR and automated fluorescent detection,” Human Genetics (1993) 92, pp. 554-562.
Craig R. Miller, et al., “Assessing Allelic Dropout and Genotype Reliability Using Maximum Likelihood,” Genetics 160, (Jan. 2002), pp. 357-366.
Jonine L. Bernstein et al., “Comparison of Techniques for the Successful Detection of BRCA1 Mutations in Fixed Paraffin-Embedded Tissue,” Cancer Epidemiology, Biomarkers and Prevention, vol. 11, (Sep. 2002), pp. 809-811.
L.G. Dressler, et al., “Policy guidelines for the utilization of formalin-fixed, paraffin-embedded tissue sections: the UNC SPORE experience,” Breast Cancer Research and Treatment 58, pp. 31-39 (1999).
M.P. Burton, et al., “Comparisoon of Histologic Stains for Use in PCR Analysis of Microdissected, Paraffin-Embedded Tissues,” BioTechniques, vol. 24, No. 1, pp. 86-91 (1998).
Cecilia Williams, et al., “A High Frequency of Sequence Alterations is Due to Formalin Fixation of Archival Specimens,” American Journal of Pathology, vol. 155, No. 5, (Nov. 1999), pp. 1467-1471.
John W. Gillespie, et al., “Evaluation of Non-Formalin Ti
Finkelstein Patricia Anne
Finkelstein Sydney David
Drinker Biddle & Reath LLP
Goldberg Jeanine A.
RedPath Integrated Pathology, Inc.
LandOfFree
Topographic genotyping does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Topographic genotyping, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topographic genotyping will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3587853